Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2018 2
2019 2
2020 2
2021 4
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Ketamine as a prophylactic resilience-enhancing agent.
Evers AG, Murrough JW, Charney DS, Costi S. Evers AG, et al. Among authors: costi s. Front Psychiatry. 2022 Jul 28;13:833259. doi: 10.3389/fpsyt.2022.833259. eCollection 2022. Front Psychiatry. 2022. PMID: 35966469 Free PMC article. Review.
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression.
Cathomas F, Bevilacqua L, Ramakrishnan A, Kronman H, Costi S, Schneider M, Chan KL, Li L, Nestler EJ, Shen L, Charney DS, Russo SJ, Murrough JW. Cathomas F, et al. Among authors: costi s. Transl Psychiatry. 2022 Jan 10;12(1):12. doi: 10.1038/s41398-021-01712-0. Transl Psychiatry. 2022. PMID: 35013133 Free PMC article.
Neuroimaging correlates and predictors of response to repeated-dose intravenous ketamine in PTSD: preliminary evidence.
Norbury A, Rutter SB, Collins AB, Costi S, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Glasgow AM, Brallier J, Shin LM, Charney DS, Murrough JW, Feder A. Norbury A, et al. Among authors: costi s. Neuropsychopharmacology. 2021 Dec;46(13):2266-2277. doi: 10.1038/s41386-021-01104-4. Epub 2021 Jul 31. Neuropsychopharmacology. 2021. PMID: 34333555 Free PMC article. Clinical Trial.
Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
Costi S, Morris LS, Kirkwood KA, Hoch M, Corniquel M, Vo-Le B, Iqbal T, Chadha N, Pizzagalli DA, Whitton A, Bevilacqua L, Jha MK, Ursu S, Swann AC, Collins KA, Salas R, Bagiella E, Parides MK, Stern ER, Iosifescu DV, Han MH, Mathew SJ, Murrough JW. Costi S, et al. Am J Psychiatry. 2021 May 1;178(5):437-446. doi: 10.1176/appi.ajp.2020.20050653. Epub 2021 Mar 3. Am J Psychiatry. 2021. PMID: 33653118 Free PMC article. Clinical Trial.
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS. Feder A, et al. Among authors: costi s. Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5. Am J Psychiatry. 2021. PMID: 33397139 Clinical Trial.
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial.
Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Stade EC, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, Murrough JW. Costi S, et al. Neuropsychopharmacology. 2019 Sep;44(10):1812-1819. doi: 10.1038/s41386-019-0365-0. Epub 2019 Mar 11. Neuropsychopharmacology. 2019. PMID: 30858518 Free PMC article. Clinical Trial.
Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder.
Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, Murrough JW. Tan A, et al. Among authors: costi s. Mol Psychiatry. 2020 Jun;25(6):1323-1333. doi: 10.1038/s41380-018-0283-2. Epub 2018 Nov 1. Mol Psychiatry. 2020. PMID: 30385872 Free PMC article. Clinical Trial.
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder.
Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW. Sayed S, et al. Among authors: costi s. Int J Neuropsychopharmacol. 2018 Jan 1;21(1):3-11. doi: 10.1093/ijnp/pyx109. Int J Neuropsychopharmacol. 2018. PMID: 29186416 Free PMC article. Clinical Trial.